1
|
Pačarić S, Kristek J, Mirat J, Kondža G, Turk T, Farčić N, Orkić Ž, Nemčić A. The quality of life of Croatian women after mastectomy: a cross-sectional single-center study. BMC Public Health 2018; 18:999. [PMID: 30097040 PMCID: PMC6086072 DOI: 10.1186/s12889-018-5929-0] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2018] [Accepted: 08/02/2018] [Indexed: 12/31/2022] Open
Abstract
Background Measuring the quality of life (QoL) of women with breast cancer is an important aspect of measuring treatment success. In Croatia, no QoL studies have been carried out with a focus on patients after mastectomy. The aim of this study was to examine QoL 1 month and 1 year after mastectomy. Methods This cross-sectional single-center study of quality of life was conducted in 101 patients, 50 of whom had undergone a mastectomy 1 month prior, and 51 of whom had undergone a mastectomy 1 year prior. The study was conducted from July 2015 to June 2016. The questionnaires used in the study were developed by the European Organisation for Research and Treatment of Cancer (EORTC). The questionnaire EORTC QLQ-C30 assesses the QoL of cancer patients, and the questionnaire EORTC QLQ-BR23 is a disease-specific breast cancer module. A chi square test, Fisher’s exact test, Kolmogorov-Smirnov test, Student’s t-test and Mann-Whitney U test were performed in the statistical analysis using the statistical program SPSS (Inc. Released 2008. SPSS Statistics for Windows, Version 17.0. Chicago: SPSS Inc.). Results Patients who had undergone a mastectomy a year earlier placed a higher value on their health state than did those who had undergone a mastectomy a month earlier. The most affected values of functional status on the EORTC QLQ-C30 scale were emotional functioning (37.5 [95% CI 33.3–61.6]) and sexual functioning (16.67 [95% CI 0–33.3]) 1 month and 1 year after mastectomy, respectively. The most affected symptoms on the EORTC QLQ-C30 scale were hair loss 66.67 [95% CI 33.3–100]) and fatigue 33.33 [95% CI 24–44]) 1 month and 1 year after mastectomy, respectively. Conclusion In our study, both functional and symptom scales were more affected in women 1 month after mastectomy. QoL was considerably improved in women 1 year after the surgery compared to 1 month after mastectomy. The results of this study could contribute to the public awareness of the QoL of breast cancer patients.
Collapse
Affiliation(s)
- Stana Pačarić
- Department of Surgery, Faculty of Medicine, University of Osijek, Osijek, Croatia. .,Department of Surgery, University Hospital Osijek, Huttlerova 4, 31000, Osijek, Croatia.
| | - Jozo Kristek
- Department of Surgery, Faculty of Medicine, University of Osijek, Osijek, Croatia.,Department of Surgery, University Hospital Osijek, Huttlerova 4, 31000, Osijek, Croatia
| | - Jure Mirat
- Faculty of Medicine, University of Osijek, Cara Hadrijana 10/E, HR, 31000, Osijek, Croatia
| | - Goran Kondža
- Department of Surgery, Faculty of Medicine, University of Osijek, Osijek, Croatia.,Department of Surgery, University Hospital Osijek, Huttlerova 4, 31000, Osijek, Croatia
| | - Tajana Turk
- Department of Biophysics and Radiology, Faculty of Medicine, University of Osijek, Osijek, Croatia.,Department of Diagnostic and Interventional Radiology, University Hospital Osijek, Huttlerova 4, 31000, Osijek, Croatia
| | - Nikolina Farčić
- Department of Surgery, University Hospital Osijek, Huttlerova 4, 31000, Osijek, Croatia.,Department of Nursing, Medical Ethics and Palliative Medicine, Faculty of Medicine, University of Osijek, Osijek, Croatia
| | - Želimir Orkić
- Department of Surgery, Faculty of Medicine, University of Osijek, Osijek, Croatia.,Department of Surgery, University Hospital Osijek, Huttlerova 4, 31000, Osijek, Croatia
| | - Ana Nemčić
- Department of Surgery, Faculty of Medicine, University of Osijek, Osijek, Croatia.,Department of Surgery, University Hospital Osijek, Huttlerova 4, 31000, Osijek, Croatia
| |
Collapse
|
2
|
Lôbo SA, Fernandes AFC, Almeida PCD, Carvalho CMDL, Sawada NO. Qualidade de vida em mulheres com neoplasias de mama em quimioterapia. ACTA PAUL ENFERM 2014. [DOI: 10.1590/1982-0194201400090] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
ObjetivoConhecer a qualidade de vida relacionada à saúde de mulheres com câncer de mama em tratamento quimioterápico.MétodosEstudo transversal realizado em instituição especializada, não qual foram incluídas 145 mulheres. Foram utilizados dois questionários padronizados de qualidade relacionada à saúde, traduzidos e validados para a lingua portuguêsa. Utilizou-se o Manual dos Escores da EORTC para calcular os escores dos domínios dos questionários.ResultadosSegundo o primeiro questionário, a função mais afetada foi a emocional. O tratamento provoca dificuldade financeira na maioria das pacientes (média = 41,83). Os sintomas com os maiores escores foram Insônia (37,93), Fadiga (36,01) e Perda de apetite (33,56). Segundo o instrumento Quality of Life Questionnaire - Breast Cancer 23, o escore Efeitos Colaterais teve média de 50,07, significando que muitas mulheres apresentam efeitos colaterais da quimioterapia e satisfação sexual prejudicada.ConclusãoMulheres com câncer de mama apresentaram alterações nos domínios emocional, financeiro, de satisfação sexual e nas perspectivas futuras. Os sintomas mais mencionados foram fadiga, insônia e perda de apetite.
Collapse
|
3
|
Souza BFD, Pires FH, Dewulf NDLS, Inocenti A, Silva AEBDC, Miasso AI. Pacientes em uso de quimioterápicos: depressão e adesão ao tratamento. Rev Esc Enferm USP 2013; 47:61-8. [DOI: 10.1590/s0080-62342013000100008] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2011] [Accepted: 05/29/2012] [Indexed: 01/06/2023] Open
Abstract
Este trabalho trata-se de estudo analítico, transversal, com abordagem quantitativa, que verificou a presença de depressão e a adesão ao tratamento com quimioterápicos em pacientes oncológicos atendidos na Farmácia Central de Quimioterapia de um hospital universitário. A amostra constou de 102 pacientes e a coleta dos dados foi realizada no período de outubro de 2010 a maio de 2011. Utilizou-se a entrevista estruturada, norteada por roteiro contendo dados sociodemográficos, clínicos e terapêuticos; o Teste de Morisky e o Inventário de Depressão de Beck. Os resultados revelaram que 10,8% e 1,9% dos participantes apresentaram depressão moderada e grave, respectivamente. Houve associação estatisticamente significativa entre a presença de depressão e as variáveis renda per capita, número de cirurgias e tempo de doença. Identificou-se falta de adesão ao tratamento em 48% dos participantes. Tais resultados indicam a necessidade de treinamento da equipe de saúde para detectar transtornos depressivos e falta de adesão ao tratamento com quimioterápicos entre pacientes oncológicos.
Collapse
|